Fund Holdings — Atle Fund Management AB

Total Portfolio Value
$26.97M
Total Bought
$107.68M
Total Sold
$86.47M
Net Transaction
+$21.21M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Avidity Biosciences Inc051,978+51,97802400.89%+240
Celcuity Inc(CELC)037,157+37,15701950.72%+195
Corbus Pharmaceuticals Holding(CRBP)175,582175,58201,2122360.87%-976
Disc medicine inc(IRON)24,65245,690+21,0381,3063211.19%-985
Janux Therapeutics Inc(JANX)49,82049,82001,1511290.48%-1,022
BICARA THERAPEUTICS INC147,380203,755+56,3751,3693421.27%-1,028
Arcellx Inc
COMMON STOCK
25,73225,73201,6942240.83%-1,470
Summit Therapeutics Inc(SMMT)92,73792,73701,9732030.75%-1,770
Mereo Biopharma Group PLC(MREO)764,901764,90102,0731670.62%-1,906
Krystal Biotech, Inc(KRYS)20,15842,191+22,0332,7717912.93%-1,980
Universal Health Services Inc(UNH)13,72713,72702,4872981.10%-2,189
NewAmsterdam Pharma Co NV
ORDINARY SHARES
157,223193,625+36,4022,8475852.17%-2,263
Autolus Therapeutics PLC(AUTL)1,105,4611,169,634+64,1732,5202020.75%-2,318
Harmony Bioscience Holdings(HRMY)86,27492,074+5,8002,7262691.00%-2,457
REVOLUTION Medicines Inc(RVMD)82,27585,355+3,0803,0274231.57%-2,604
Merus N.V.59,88947,999-11,8903,1504801.78%-2,670
Soleno Therapeutics Inc40,53260,156+19,6243,3964321.60%-2,964
iRhythm Technologies Inc(IRTC)25,30229,991+4,6893,8955482.03%-3,348
Edwards Lifesciences Corp57,36065,659+8,2994,4865422.01%-3,944
Cardinal Health Inc(CAH)26,79730,297+3,5004,5025051.87%-3,997
Dexcom Inc(DXCM)50,87250,87204,4413631.35%-4,077
VERONA PHARMA PLC - ADR47,1000-47,1004,4550—-4,455
Mirum Pharmaceuticals Inc(MIRM)106,91293,605-13,3075,4417292.70%-4,712
BeiGene Ltd(ONC)24,38630,333+5,9475,9031,0974.07%-4,806
UFP Technologies Inc(UFPT)21,88622,986+1,1005,3444871.81%-4,857
Alkermes PLC(ALKS)227,224252,875+25,6516,5018052.99%-5,695
Bridgebio Pharma Inc(BBIO)165,480174,722+9,2427,1459633.57%-6,182
Amgen Inc(AMGN)23,89413,806-10,0886,6714141.53%-6,258
Gilead Sciences Inc(GILD)73,16578,169+5,0048,1129213.42%-7,191
Thermo Fisher Scientific Corp(TMO)24,26627,147+2,8819,8391,3985.18%-8,441
Cencora Inc31,46628,608-2,8589,4359493.52%-8,486
Intuitive Surgical Inc18,55919,707+1,14810,0859363.47%-9,149
Neurocrine Biosciences Inc(NBIX)88,392102,625+14,23311,1101,5295.67%-9,581
Merck & Co. Inc(MRK)139,172160,913+21,74111,0171,4345.32%-9,583
Stryker Corporation(SYK)27,46622,769-4,69710,8668943.31%-9,973
Vertex Pharmaceuticals Inc(VRTX)24,32817,766-6,56210,8317392.74%-10,092
Boston Scientific Corp(BSX)126,18586,680-39,50513,5548983.33%-12,655
AbbVie Inc(ABBV)86,93392,105+5,17216,1372,2648.40%-13,872
Eli Lilly & Co(LLY)38,72137,244-1,47730,1843,01711.19%-27,167
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q3 2025 | TickerTrail